Aluminum hydroxide 200 mg / magnesium hydroxide 200 mg / simethicone 20 mg Chewable Tablet
RxNorm 317055
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 317055 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: aluminum hydroxide 200 mg / magnesium hydroxide 200 mg / simethicone 20 mg Chewable Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Aluminum hydroxide 200 mg / magnesium hydroxide 200 mg / simethicone 20 mg Chewable Tablet
(Atom ID: 12339973)
PSN
Prescribable Name (PSN):
Aluminum hydroxide 200 mg / magnesium hydroxide 200 mg / simethicone 20 mg Chewable Tablet
(Atom ID: 6366988)
SY